Thrombospondin‐1 is an inhibitor of pharmacological activation of soluble guanylate cyclase

No abstract is available for this paper.

• Publication year

  2010

• Venue

  British Journal of Pharmacology

• Publication date

  2010-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.2009.00631.xPMID 20233213PMCID PMC2850410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses*

  2009cited by this paper
• Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress.

  2009cited by this paper
• Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.

  2008influential reference
• Binding of YC-1 or BAY 41-2272 to soluble guanylyl cyclase induces a geminate phase in CO photolysis.

  2008cited by this paper
• Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Activator Cinaciguat (BAY 58‐2667) in Healthy Male Volunteers

  2008cited by this paper
• CD47: a new target in cardiovascular therapy.

  2008influential reference
• Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.

  2008cited by this paper
• Gene Silencing of CD47 and Antibody Ligation of Thrombospondin-1 Enhance Ischemic Tissue Survival in a Porcine Model: Implications for Human Disease

  2008cited by this paper
• Thrombospondin-1 Is an Adipokine Associated With Obesity, Adipose Inflammation, and Insulin Resistance

  2008cited by this paper
• Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.

  2007cited by this paper
• Increasing Survival of Ischemic Tissue by Targeting CD47

  2007influential reference
• Blocking Thrombospondin-1/CD47 Signaling Alleviates Deleterious Effects of Aging on Tissue Responses to Ischemia

  2007influential reference
• Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier?

  2007cited by this paper
• Gastric motility in soluble guanylate cyclase α1 knock‐out mice

  2007cited by this paper
• Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.

  2007influential reference
• Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses.

  2006cited by this paper
• CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1*

  2006cited by this paper
• NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

  2006influential reference
• Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.

  2005influential reference
• Thrombospondin-1 is Induced in Rat Myocardial Infarction and Its Induction is Accelerated by Ischemia/Reperfusion

  2005cited by this paper
• Explaining the phenomenon of nitrate tolerance.

  2005cited by this paper
• Critical overexpression of thrombospondin 1 in chronic leg ischaemia

  2005cited by this paper
• Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?

  2004cited by this paper
• NO-independent regulatory site on soluble guanylate cyclase

  2001cited by this paper
• A molecular basis for nitric oxide sensing by soluble guanylate cyclase.

  1999cited by this paper
• Kinetics and equilibria of soluble guanylate cyclase ligation by CO: effect of YC-1.

  1999cited by this paper
• Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia.

  1998influential reference
• Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries.

  1998cited by this paper
• Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes.

  1998cited by this paper
• The use of nitric oxide donors in pharmacological studies

  1998cited by this paper
• Circulating and cellular markers of endothelial dysfunction with aging in rats.

  1997cited by this paper
• Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris

  1996cited by this paper
• Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): characterization of Fe(II)sGC and Fe(II)sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate the enzyme.

  1995cited by this paper
• Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states.

  1994cited by this paper
• Purification of thrombospondin from human platelets

  1994influential reference
• Soluble Guanylyl Cyclase and Platelet Function a

  1994cited by this paper
• Cyanide Toxicity from Sodium Nitroprusside: Risks and Management

  1992cited by this paper
• Nitric oxide as a neuronal messenger.

  1991cited by this paper
• Physiology of thrombospondin.

  1990influential reference
• Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain

  1988cited by this paper
• Thrombospondin in Clinical Disease States

  1987cited by this paper
• Soluble guanylate cyclase from rat lung exists as a heterodimer.

  1986cited by this paper
• Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms.

  1986cited by this paper
• The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation.

  1985cited by this paper
• Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins.

  1984cited by this paper
• Soluble guanylate cyclase purified from bovine lung contains heme and copper

  1981cited by this paper
• Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators.

  1981cited by this paper
• Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.

  1977cited by this paper

• Per-ARNT-Sim domains in nitric oxide signaling by soluble guanylyl cyclase.

  2023cites this paper
• Extracellular Matrix Glycoprotein Thrombospondin 1: An Overlooked Pathological Mediator in Vasculopathy of Systemic Sclerosis-Secondary Raynaud’s Phenomena

  2023cites this paper
• The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders

  2022cites this paper
• Indirect mediators of systemic health outcomes following nanoparticle inhalation exposure.

  2022cites this paper
• Thrombospondin-1 Plays a Major Pathogenic Role in Experimental and Human Bronchopulmonary Dysplasia.

  2022cites this paper
• Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine

  2021influential citation
• Novel Pharmaceutical Strategy for Selective Abrogation of TSP1-Induced Vascular Dysfunction by Decoy Recombinant CD47 Soluble Receptor in Prophylaxis and Treatment Models

  2021cites this paper
• Efficient Ex Vivo Screening of Agents Targeting Thrombospondin1-Induced Vascular Dysfunction Using a Digital Multiwire Myograph System

  2021cites this paper
• A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis

  2021cites this paper
• Activation of soluble guanylyl cyclase signalling with cinaciguat improves impaired kidney function in diabetic mice

  2021cites this paper
• CD47 as a potential biomarker for the early diagnosis of severe COVID-19

  2021cites this paper
• Extracellular Matrix Dynamics in Vascular Remodeling.

  2020cites this paper
• Mathematical Model Predicts Effective Strategies to Inhibit VEGF-eNOS Signaling

  2020cites this paper
• Is CD47 a potentially promising therapeutic target in cardiovascular diseases? - Role of CD47 in cardiovascular diseases.

  2020cites this paper
• Gaso-Transmitters Nitric oxide : what ’ s new to NO ?

  2017cites this paper
• Thrombospondin-1, Free Radicals, and the Coronary Microcirculation: The Aging Conundrum

  2017cites this paper
• Thrombospondin-1 mediates multi-walled carbon nanotube induced impairment of arteriolar dilation

  2017cites this paper
• Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

  2017cites this paper
• Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer

  2017cites this paper
• Physiological levels of thrombospondin-1 decrease NO-dependent vasodilation in coronary microvessels from aged rats.

  2016cites this paper
• The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension

  2016cites this paper
• Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody

  2016cites this paper
• CD47 signaling pathways controlling cellular differentiation and responses to stress

  2015cites this paper
• Thrombospondin-1-Based Antiangiogenic Therapy

  2015cites this paper
• Platelet hyperaggregability in patients with atrial fibrillation

  2015cites this paper
• Reversal of hyperglycemia: effects on nitric oxide signaling.

  2015cites this paper
• Variability of nitric oxide signalling in atrial fibrillation: potential modulation.

  2015influential citation
• Interfacial Residues Promote an Optimal Alignment of the Catalytic Center in Human Soluble Guanylate Cyclase: Heterodimerization Is Required but Not Sufficient for Activity

  2014cites this paper
• Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow

  2014cites this paper
• Aging of the Nitric Oxide System: Are We as Old as Our NO?

  2014cites this paper
• Aging of Platelet Nitric Oxide Signaling: Pathogenesis, Clinical Implications, and Therapeutics

  2014cites this paper
• Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.

  2014cites this paper
• Nitric Oxide and Heat Shock Protein 90 Activate Soluble Guanylate Cyclase by Driving Rapid Change in Its Subunit Interactions and Heme Content*

  2014cites this paper
• Thrombospondins: old players, new games

  2013cites this paper
• Decreased TSP-1 following percutaneous coronary intervention is associated with major adverse cardiac events in ST-elevation myocardial infarction

  2013cites this paper
• Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.

  2013cites this paper
• Evolution of Extracellular Matrix

  2013cites this paper
• Membrane Protein Complexes Involved in Thrombospondin-1 Regulation of Nitric Oxide Signaling

  2013cites this paper
• Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47

  2013cites this paper
• Thrombospondins and Their Receptors: Evolving Functions

  2013cites this paper
• CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest

  2012cites this paper
• Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients.

  2012cites this paper
• Рамиприл повышает чувствительность тромбоцитов к оксиду азота. Значение этого феномена для лечения больных с высоким сердечно-сосудистым риском

  2012cites this paper
• Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.

  2012cites this paper
• The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.

  2012cites this paper
• Activated CD 47 regulates multiple vascular and stress responses : implications for acute kidney injury and its management

  2012cites this paper
• Pathogenesis of aortic stenosis : implications regarding impairment of nitric oxide signalling.

  2012cites this paper
• The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Inhibits Vascular Smooth Muscle Growth through the cAMP-Dependent Protein Kinase and cGMP-Dependent Protein Kinase Pathways

  2011cites this paper
• Role of Thrombospondin-1 in pulmonary hypertension : a proof of concept

  2011cites this paper
• Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47.

  2011cites this paper
• Therapies using anti-angiogenic peptide mimetics of thrombospondin-1

  2011influential citation
• Thrombospondin‐1 and Angiotensin‐II inhibit soluble guanylyl cylase through an increase in intracellular calcium concentration

  2011cites this paper
• Nitric oxide: a guardian for vascular grafts?

  2011cites this paper
• Amyloid-β Inhibits No-cGMP Signaling in a CD36- and CD47-Dependent Manner

  2010cites this paper
• Binding Studies of Membrane Receptor CD47 with the C-terminal Domain of Thrombospondin-1

  2010cites this paper
• Amyloid-b Inhibits No-cGMP Signaling in a CD 36-and CD 47-Dependent Manner

  2010cites this paper